power morcellator cancer

Letter to the FDA Addresses Risks of Power Morcellator Cancer

by Staff Blogger | December 29th, 2015

Controversy continues to swirl around the use of a device known as the power morcellator to remove uterine fibroids from the bodies of women.

In 2014, the U.S. Food and Drug Administration (FDA) ordered doctors and surgeons to discontinue the use of the power morcellator when performing procedures like hysterectomies due to an increased risk of the patient developing cancer. Research linked the disease to the device after it was discovered that dormant cancerous cells could be released into the body by the device, which led to several power morcellator cancer lawsuits being filed.

Doctors are now contesting these claims, saying the FDA relied on flawed research when issuing the ruling. An article from Reuters explains the medical professionals say the studies that were used during the FDA’s decision-making process were flawed and lacked credibility. For instance, the studies included three cases where the patient developed leiomyoma, which doesn’t meet the current standards and definitions for cancer.

The doctors go on to claim that making women undergo more invasive procedures than the use of the power morcellator increases the risks for hospital-acquired infections and other surgical complications, including death.

The legal staff at Ferrer, Poirot & Wansbrough recognize the dangers the use of a defective medical product can pose to patients and our team is anxiously awaiting the FDA’s response to the claims that have recently been made regarding the use of the power morcellator during surgery.

Power Morcellator Cancer Lawsuits Consolidated Into Multidistrict Litigation

by Staff Blogger | October 20th, 2015

Power morcellators are medical devices that can perform hysterectomies and other medical procedures in a less invasive manner than traditional surgical methods. However, the device lost credibility when it was discovered it can significantly increase the chances of developing cancer in some women.

Researchers found that when the morcellator is used, dormant cancerous cells can be released into the body, where they can later metastasize into tumors. Data from the U.S. Food and Drug Administration shows at least 1-in-350 women are at an increased risk of developing power morcellator cancer when the devices are used.

These discoveries have led to hundreds of lawsuits being filed against the makers of the devices, claiming victims were not warned of the risks before undergoing a power morcellator surgery. Now, these cases are being consolidated into multidistrict litigation.

According to KCUR 98.3 Radio, more than two dozen power morcellator cancer lawsuits—a majority of which are filed against device manufacturer Ethicon— have been moved to a Kansas City, Kansas, federal court to be heard. U.S. District Judge, Kathryn H. Vratil, has been assigned to preside over the case.

The legal staff at Ferrer, Poirot & Wansbrough believe in holding companies accountable for the safety of the products they make. That’s why our defective medical device lawyers are hopeful a decision in the cases will bring a sense of closure to individuals harmed by morcellators.